Regisry of the Stroke Patients in Assiut University Hospital

NCT ID: NCT03392792

Last Updated: 2018-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-30

Study Completion Date

2018-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

• Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tissue plasmnogen activator

Group Type ACTIVE_COMPARATOR

tissue plasminogen activator

Intervention Type DRUG

role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA

thrombectoy

Group Type ACTIVE_COMPARATOR

thrombectomy

Intervention Type PROCEDURE

role of thrombectomy in patient with acute ischemic stroke

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tissue plasminogen activator

role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA

Intervention Type DRUG

thrombectomy

role of thrombectomy in patient with acute ischemic stroke

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

rtpa

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with stroke aged ≥18 years of both sex
* Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks

Exclusion Criteria

* Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
* Stroke due to Brain tumors
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Noura Abdel hakim abdel Mohsen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Assiut u

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Giessen Stroke Registry
NCT05295862 RECRUITING